KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Progyny (PGNY) Revenue (2018 - 2025)

Progyny (PGNY) has disclosed Revenue for 8 consecutive years, with $318.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Revenue changed N/A to $318.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $975.3 million, a N/A change, with the full-year FY2025 number at $1.3 billion, changed N/A from a year prior.
  • Revenue was $318.4 million for Q4 2025 at Progyny, down from $332.9 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $332.9 million in Q2 2025 to a low of $122.1 million in Q1 2021.
  • A 5-year average of $234.5 million and a median of $264.2 million in 2023 define the central range for Revenue.
  • Peak YoY movement for Revenue: surged 99.13% in 2021, then increased 2.04% in 2024.
  • Progyny's Revenue stood at $127.6 million in 2021, then skyrocketed by 68.03% to $214.3 million in 2022, then increased by 25.95% to $269.9 million in 2023, then grew by 6.18% to $286.6 million in 2024, then increased by 11.09% to $318.4 million in 2025.
  • Per Business Quant, the three most recent readings for PGNY's Revenue are $318.4 million (Q4 2025), $332.9 million (Q2 2025), and $324.0 million (Q1 2025).